HilleVax, Inc.

HLVX · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$5,266-$6,061-$33,947-$25,823
Dep. & Amort.$478$490$854$842
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,330$2,429$4,479$5,050
Change in WC$2,532-$8,920$2,522-$7,623
Other Non-Cash-$863-$656$7,904-$268
Operating Cash Flow-$789-$12,718-$18,188-$27,822
Investing Activities
PP&E Inv.$0$0-$110$13,613
Net Acquisitions$0$0$0$0
Inv. Purchases-$6,019-$111,264$1-$15,694
Inv. Sales/Matur.$18,000$17,000$69,000$68,045
Other Inv. Act.$0$0$0-$15,325
Investing Cash Flow$11,981-$94,264$68,891$50,639
Financing Activities
Debt Repay.$0$0$0-$27,497
Stock Issued$0$0$790-$790
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$790$790
Financing Cash Flow$0$0$0-$27,497
Forex Effect$0$0$0$0
Net Chg. in Cash$11,192-$106,982$50,703-$4,680
Supplemental Information
Beg. Cash$49,116$156,098$105,395$110,075
End Cash$60,308$49,116$156,098$105,395
Free Cash Flow-$789-$12,718-$18,298-$29,534
HilleVax, Inc. (HLVX) Financial Statements & Key Stats | AlphaPilot